BOSTON SCIENTIFIC CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
BOSTON SCIENTIFIC CORPORATION (BSX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $16.83 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-20.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2024-02-20
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $16.83, a 23.39% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $13.64, a 26.65% increase from fiscal 2021.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $10.77, a 3.16% increase from fiscal 2020.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $10.44, a 11.22% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2023-12-31 | $16.83 10-K · filed 2024-02-20 |
| 2022-12-31 | $13.64 10-K · filed 2024-02-20 |
| 2021-12-31 | $10.77 10-K · filed 2024-02-20 |
| 2020-12-31 | $10.44 10-K · filed 2023-02-23 |
| 2019-12-31 | $11.76 10-K · filed 2022-02-23 |
| 2018-12-31 | $8.55 10-K · filed 2021-02-23 |
| 2017-12-31 | $7.16 10-K · filed 2020-02-25 |
| 2016-12-31 | $5.60 10-K · filed 2019-02-19 |
| 2015-12-31 | $5.54 10-K · filed 2018-02-20 |
| 2014-12-31 | $5.07 10-K · filed 2017-02-23 |
| 2013-12-31 | $2.84 10-K · filed 2016-02-24 |
| 2012-12-31 | $2.60 10-K · filed 2015-02-25 |
| 2011-12-31 | $3.07 10-K · filed 2014-02-26 |
| 2010-12-31 | $3.11 8-K · filed 2013-05-29 |
| 2009-12-31 | $3.92 10-K · filed 2012-02-17 |
| 2008-12-31 | $4.44 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |